Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Assessment and Management of Stroke

neuroscienceCME Multimedia Snack

Premiere Date: Friday, April 27, 2012

This activity offers CE credit for:

1. Physicians (CME)
2. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Saturday, April 27, 2013
Note: Credit Is No Longer Available

Faculty

Ned H. Kalin, MD  Hedberg Professor and Chair Department of Psychiatry University of Wisconsin School of Medicine and Public Health--Madison Director, HealthEmotions Research Institute Madison, WI Editor-in-Chief – American Journal of Psychiatry

José Biller, MD, FACP, FAAN, FAHA  Professor and Chairman Department of Neurology Loyola University Chicago Stritch School of Medicine Maywood, IL

Statement of Need

The term stroke is most commonly used by both physicians and the general public to refer to any one of the diverse group of disorders resulting from either ischemia or hemorrhage within the central nervous system. Stroke is the third leading cause of death after cardiovascular disease and cancer and is a primary cause of long-term disability in much of the industrialized world. Stroke is also the most common neurological condition necessitating hospitalization.(1)

Yet even with the risks defined and the prevention strategies proven, the incidence of stroke has not decreased significantly in recent years. Although they are scientifically validated and widely accepted, strategies for stroke prevention such as lifestyle changes, weight management, smoking cessation, and control of hypertension and diabetes are not effectively implemented.(2)

This neuroscienceCME Snack presents an informative video interview with leading stroke expert José Biller, MD, in an important review of the serious manifestations of stroke and a clinical update for all clinicians.

---

1. Biller J. Ischemic cerebrovascular disease. In: Biller J, ed. Practical Neurology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009: pp. 461-478.
2. Furie KL, Kelly PJ. Handbook of Stroke Prevention in Clinical Practice. Vol 1. Totowa, NJ: Humana; 2004: pp. vii.

Activity Goal

To improve awareness and understanding of stroke and educate patients about stroke risk factors.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Describe and differentiate the modifiable and nonmodifiable risk factors for stroke.
• Evaluate patients for risk factors of stroke and communicate with patients about these risk factors.

Financial Support

Funding for this CME activity is provided by CME Outfitters, LLC.

Target Audience

Physicians and other health care professionals with an interest in stroke.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Kalin has disclosed that he serves on the advisory boards of CeNeRx BioPharma; CME Outfitters, LLC; Corcept Therapeutics; Elsevier; Janssen L.P.; and Letters & Sciences. He is a stockholder of/has equity options in CeNeRx BioPharma and Corcept Therapeutics. Dr. Kalin is the owner of Promoter Neurosciences, LLC, and holds patents for the following: promoter sequences for corticotropin-releasing factor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences (U.S. Patent issued on 07-04-06; patent #7071323, U.S. Patent issued on 05-12-09; patent #7,531,356); promoter sequences for urocortin II and the use thereof (U.S. Patent issued on 08-08-06; patent #7087385); and promoter sequences for corticotropin-releasing factor binding protein and use thereof (U.S. Patent issued on 10-17-06; patent #7122650).

Dr. Biller has no disclosures to report.

Tony Graham, MD (content/peer reviewer) has no disclosures to report.

Robert Kennedy (planning committee) has no disclosures to report.

Sandra Haas Binford, MEd (planning committee) has no disclosures to report.

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Joy B. Leffler, MLA, NASW (planning committee) has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CME activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC and the faculty, do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).